Thanks - I had a late night. The scoping studies are due at the end of March 2019 not the DFS which is still due Q2 2019.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025